BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 36259505)

  • 21. Therapeutic Nanoparticles and Their Targeted Delivery Applications.
    Yetisgin AA; Cetinel S; Zuvin M; Kosar A; Kutlu O
    Molecules; 2020 May; 25(9):. PubMed ID: 32397080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanotechnology-Based Drug Delivery Systems in the Transdermal Treatment of Melanoma.
    Saeidi Z; Giti R; Rostami M; Mohammadi F
    Adv Pharm Bull; 2023 Nov; 13(4):646-662. PubMed ID: 38022807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanotechnology in leukemia: diagnosis, efficient-targeted drug delivery, and clinical trials.
    Salama MM; Aborehab NM; El Mahdy NM; Zayed A; Ezzat SM
    Eur J Med Res; 2023 Dec; 28(1):566. PubMed ID: 38053150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unlocking nature's arsenal: Nanotechnology for targeted delivery of venom toxins in cancer therapy.
    Chary PS; Shaikh S; Rajana N; Bhavana V; Mehra NK
    Biomater Adv; 2024 May; 162():213903. PubMed ID: 38824828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success.
    Kumbhar PR; Kumar P; Lasure A; Velayutham R; Mandal D
    Discov Nano; 2023 Dec; 18(1):156. PubMed ID: 38112935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances of Nanotechnology in the Diagnosis and Treatment of Hepatocellular Carcinoma.
    Escutia-Gutiérrez R; Sandoval-Rodríguez A; Zamudio-Ojeda A; Guevara-Martínez SJ; Armendáriz-Borunda J
    J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Use of Lipid-Based Nanocarriers to Improve Ovarian Cancer Treatment: An Overview of Recent Developments.
    Tantray J; Patel A; Prajapati BG; Kosey S; Bhattacharya S
    Curr Pharm Biotechnol; 2024 Feb; ():. PubMed ID: 38357950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Development of Nanoparticles for the Detection and Imaging of Ovarian Cancers.
    Henderson E; Huynh G; Wilson K; Plebanski M; Corrie S
    Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of high-resolution imaging in the evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy.
    Khosravi-Darani K; Pardakhty A; Honarpisheh H; Rao VS; Mozafari MR
    Micron; 2007; 38(8):804-18. PubMed ID: 17669661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanotechnology in Retinal Disease: Current Concepts and Future Directions.
    Mehta NJ; Mehta SN
    J Ocul Pharmacol Ther; 2024; 40(1):3-12. PubMed ID: 38052063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microfluidic production of amiodarone loaded nanoparticles and application in drug repositioning in ovarian cancer.
    Saorin A; Saorin G; Duzagac F; Parisse P; Cao N; Corona G; Cavarzerani E; Rizzolio F
    Sci Rep; 2024 Mar; 14(1):6280. PubMed ID: 38491077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organelle Targeted Drug Delivery: Key Challenges, Recent Advancements and Therapeutic Implications.
    Singh D
    Endocr Metab Immune Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38303531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Developments in Nanotechnology and Immunotherapy for the Diagnosis and Treatment of Pancreatic Cancer.
    Sindhi K; Kanugo A
    Curr Pharm Biotechnol; 2024 Feb; ():. PubMed ID: 38415488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empowering lung cancer treatment: Harnessing the potential of natural phytoconstituent-loaded nanoparticles.
    Siddiquee T; Bhaskaran NA; Nathani K; Sawarkar SP
    Phytother Res; 2024 May; ():. PubMed ID: 38806412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticles for Cancer Therapy: Current Progress and Challenges.
    Gavas S; Quazi S; Karpiński TM
    Nanoscale Res Lett; 2021 Dec; 16(1):173. PubMed ID: 34866166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles.
    Singh AP; Biswas A; Shukla A; Maiti P
    Signal Transduct Target Ther; 2019; 4():33. PubMed ID: 31637012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible role of nanocarriers in drug delivery against cervical cancer.
    Gupta S; Gupta MK
    Nano Rev Exp; 2017; 8(1):1335567. PubMed ID: 30410707
    [No Abstract]   [Full Text] [Related]  

  • 38. Polymeric Nanoparticle Delivery of Combination Therapy with Synergistic Effects in Ovarian Cancer.
    Levit SL; Tang C
    Nanomaterials (Basel); 2021 Apr; 11(4):. PubMed ID: 33923947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendrimer Technology in Glioma: Functional Design and Potential Applications.
    Gaitsch H; Hersh AM; Alomari S; Tyler BM
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Potential of Nanotechnology to Replace Cancer Stem Cells.
    Amanat MA; Farrukh A; Ishaq MUBM; Bin Shafqat B; Haidri SH; Amin R; Sameen R; Kamal T; Riaz MN; Quresh W; Ikram R; Ali GM; Begum S; Bangash SAK; Kaleem I; Bashir S; Khattak SH
    Curr Stem Cell Res Ther; 2024; 19(6):820-831. PubMed ID: 37264662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.